Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-02-28 @ 10:52 PM
Study NCT ID:
NCT01556568
Status:
WITHDRAWN
Last Update Posted:
2020-10-06
First Post:
2012-03-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
Sponsor:
Array Biopharma, now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2017-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2012-03-15
First Submit QC Date:
None
Study First Post Date:
2012-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-02
Last Update Post Date:
2020-10-06
Last Update Post Date Type:
ACTUAL